Ready to transform the future of drug discovery and development with digitally enabled technologies and AI? The Merck Digital Sciences Studio (MDSS) is back and recruiting startups for its 9-month program in Canada! In partnership with Centech Mtl and CQDM, the program offers exclusive access to Merck experts, personalized mentoring from Entrepreneurs-in-Residence, high-level workshops, powerful…
Lutter contre les maladies respiratoires, en particulier dans les hôpitaux Montréal, Canada – October 8, 2025 – Glycovax Pharma today announced a strategic collaboration with the National Research Council of Canada (NRC) and the Faculty of Veterinary Medicine at the Université de Montréal to develop a glycoconjugate vaccine against Pseudomonas aeruginosa (Pa) infections. Funding for…
Announcement Montreal, October 6, 2025 – CQDM is proud to announce the funding of an artificial intelligence (AI) innovation project aimed at improving the diagnosis of pancreatic neuroendocrine tumors. This project, with a total value of $395,255, is led by two Quebec-based companies, Vega BioImagerie and Aurora mScope, in collaboration with the Centre hospitalier de…
Welcome to Koffi Locoh, our new Chief Accountant at CQDM! 🎉 Holder of a graduate diploma (DESS) in accounting from the Université de Sherbrooke, he earned his CPA designation in 2024. With more than 16 years of experience in accounting, including 12 years in accounting firms, he has strong expertise in team supervision, financial statement…
On September 23, we hosted the very first edition of our morning Connect-Café series, an exclusive event reserved for our “network” members. This inaugural meeting focused on a crucial theme for our sector: intellectual property and open science. More than 20 CQDM network members gathered to discuss the challenges and strategies related to intellectual property…
Announcement MONTREAL, September 25, 2025 – CQDM and Brain Canada are proud to announce funding for five large-scale collaborative research projects that bring together academic, clinical, and industry partners across the country. These projects aim to transform promising scientific advances into concrete medical innovations. Funding has been made possible through grants from the Government of…
New Member Joins CQDM’s Board of Directors: A Strategic Health Innovation Expert CQDM is proud to welcome Stephanie Michaud to its Board of Directors.A close partner of the organization since its early days, she brings in-depth knowledge of our mission, activities, and evolution. A recognized expert in health innovation and innovation policy, Stéphanie is a…
We’ve officially launched the first-ever Canadian cohort of the Merck Digital Sciences Studio (MDSS), right here in Québec — with the presence of Mr. Christopher Skeete, Minister for the Economy at Québec’s Ministry of Economy, Innovation and Energy. His participation highlights the province’s commitment to digital health innovation. This global program is locally powered by…
Announcement Montreal, June 19, 2025 – CQDM and the Stem Cell Network (SCN) join forces to fund a cutting-edge collaborative research project. It aims to evaluate the potential of an encapsulated liver tissue, developed by Morphocell Technologies, to treat urea cycle disorders in children. This research and development project, worth a total of $727,507, is…
CQDM is proud to highlight a major recognition awarded to its outgoing President and CEO, Diane Gosselin, who received the Community Leadership Award – Research & Innovation as part of BIOTECanada’s Gold Leaf Awards 2025. The award was presented in Boston, during the BIO 2025 International Convention—one of the world’s largest gatherings in the biopharmaceutical…